| Literature DB >> 26187413 |
Jochem H Bernink1, Lisette Krabbendam1, Kristine Germar1, Esther de Jong1, Konrad Gronke2, Michael Kofoed-Nielsen2, J Marius Munneke3, Mette D Hazenberg3, Julien Villaudy4, Christianne J Buskens5, Willem A Bemelman5, Andreas Diefenbach2, Bianca Blom1, Hergen Spits6.
Abstract
Human group 1 ILCs consist of at least three phenotypically distinct subsets, including NK cells, CD127(+) ILC1, and intraepithelial CD103(+) ILC1. In inflamed intestinal tissues from Crohn's disease patients, numbers of CD127(+) ILC1 increased at the cost of ILC3. Here we found that differentiation of ILC3 to CD127(+) ILC1 is reversible in vitro and in vivo. CD127(+) ILC1 differentiated to ILC3 in the presence of interleukin-2 (IL-2), IL-23, and IL-1β dependent on the transcription factor RORγt, and this process was enhanced in the presence of retinoic acid. Furthermore, we observed in resection specimen from Crohn's disease patients a higher proportion of CD14(+) dendritic cells (DC), which in vitro promoted polarization from ILC3 to CD127(+) ILC1. In contrast, CD14(-) DCs promoted differentiation from CD127(+) ILC1 toward ILC3. These observations suggest that environmental cues determine the composition, function, and phenotype of CD127(+) ILC1 and ILC3 in the gut.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26187413 DOI: 10.1016/j.immuni.2015.06.019
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745